» Articles » PMID: 22260895

Clinical Utility of Three-dimensional Contrast-enhanced Ultrasound in the Differentiation Between Noninvasive and Invasive Neoplasms of Urinary Bladder

Overview
Journal Eur J Radiol
Specialty Radiology
Date 2012 Jan 21
PMID 22260895
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The purpose of this study was to evaluate the effectiveness of three-dimensional contrast-enhanced ultrasound in differentiating invasive and noninvasive neoplasms of urinary bladder.

Methods: A total of 60 lesions in 60 consecutive patients with bladder tumors received three dimensional ultrasonography, low acoustic power contrast enhanced ultrasonography and low acoustic power three-dimensional contrast-enhanced ultrasound examination. The IU22 ultrasound scanner and a volume transducer were used and the ultrasound contrast agent was SonoVue. The contrast-specific sonographic imaging modes were PI (pulse inversion) and PM (power modulation). The three dimensional ultrasonography, contrast enhanced ultrasonography, and three-dimensional contrast-enhanced ultrasound images were independently reviewed by two readers who were not in the images acquisition. Images were analyzed off-site. A level of confidence in the diagnosis of tumor invasion of the muscle layer was assigned on a 5° scale. Receiver operating characteristic analysis was used to assess overall confidence in the diagnosis of muscle invasion by tumor. Kappa values were used to assess inter-readers agreement. Histologic diagnosis was obtained for all patients.

Results: Final pathologic staging revealed 44 noninvasive tumors and 16 invasive tumors. Three-dimensional contrast-enhanced ultrasound depicted all 16 muscle-invasive tumors. The diagnostic performance of three-dimensional contrast-enhanced ultrasound was better than those of three dimensional ultrasonography and contrast enhanced ultrasonography. The receiver operating characteristic curves were 0.976 and 0.967 for three-dimensional contrast-enhanced ultrasound, those for three dimensional ultrasonography were 0.881 and 0.869, those for contrast enhanced ultrasonography were 0.927 and 0.929. The kappa values in the three dimensional ultrasonography, contrast enhanced ultrasonography and three-dimensional contrast-enhanced ultrasound for inter-reader agreements were 0.717, 0.794 and 0.914.

Conclusion: Three-dimensional contrast-enhanced ultrasound imaging, with contrast-enhanced spatial visualization is clinical useful for differentiating invasive and noninvasive neoplasms of urinary bladder objectively.

Citing Articles

Omniview of three-dimensional ultrasound for prospective evaluation of extrathyroidal extension of differentiated thyroid cancer.

Liu R, Jiang Y, Lai X, Wang Y, Gao L, Zhu S BMC Med Imaging. 2025; 25(1):42.

PMID: 39930356 PMC: 11809096. DOI: 10.1186/s12880-025-01572-w.


The Current Role of Contrast-Enhanced Ultrasound (CEUS) in the Diagnosis and Staging of Bladder Cancer: A Review of the Available Literature.

Santarelli V, Rosati D, Canale V, Salciccia S, Di Lascio G, Bevilacqua G Life (Basel). 2024; 14(7).

PMID: 39063611 PMC: 11278273. DOI: 10.3390/life14070857.


Contemporary status of diagnostic endoluminal ultrasound and optical coherence tomography in the ureter.

Sii S, Bolton J, Tempo J, Bolton D BJUI Compass. 2024; 5(6):514-523.

PMID: 38873352 PMC: 11168776. DOI: 10.1002/bco2.352.


Diagnostic Accuracy of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Muscle-Invasive Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis.

Tufano A, Rosati D, Moriconi M, Santarelli V, Canale V, Salciccia S Curr Oncol. 2024; 31(2):818-827.

PMID: 38392054 PMC: 10888477. DOI: 10.3390/curroncol31020060.


Three-dimensional ultrasound-based radiomics nomogram for the prediction of extrathyroidal extension features in papillary thyroid cancer.

Lu W, Mao L, Li J, OuYang L, Chen J, Chen S Front Oncol. 2023; 13:1046951.

PMID: 37681026 PMC: 10482087. DOI: 10.3389/fonc.2023.1046951.